Yamashiro is an Associate Clinical Professor and Program Coordinator for the MS Biomedical Diagnostics program. He researches technology assessment and development in the healthcare field with a core strength in diagnostics.

Dr. Murugan studies epigenetic changes to environmental exposures and develops epigenetic-biomarker based diagnostic tests to detect exposures to toxic chemicals, pathogens, explosives and radiological agents.

The Smith group specializes in developing novel imaging technologies and multiomic biomarker discovery towards applications in women’s health and mental illness.

Dr. Chung is a biostatistician with expertise in clinical trials, epidemiology studies, and biomarker studies.

Yu completed MSN/PhD at Penn and postdoc at Penn State and is a Fellow of Gerontological Society of the America and American Academy of Nursing. Her research focus on interventions to prevent and treat Alzheimer's disease.

Klein’s research combines computational and experimental studies of protein structure, dynamics and function with particular emphasis on membrane proteins.